Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
0Customers
0Debt Items
2Related Chains
Source-Backed Evidence Depth
MIRA Pharmaceuticals, Inc. (MIRA) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
2Total relationships
1Distinct source URLs
1High confidence
0.820Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
MIRA Pharmaceuticals, Inc. Suppliers
Ticker
Name
Confidence
Evidence
MIRALOGX-LLC
MIRALOGX-LLC
92%
Pursuant to the License Agreement, Miralogx granted the Company worldwide exclusive rights under certain intellectual property
Reciprocal relationship from QCLS graph: ivate Placements, the exercise price of the Series F Warrants was reduced to $ 181.60 per share pursuant to the full ratchet anti-dilution provisions containe…
MIRA Pharmaceuticals, Inc. Customers
No clients on recordNo downstream customers found in our database for MIRA Pharmaceuticals, Inc..
MIRA Pharmaceuticals, Inc. Debt Obligations
No debt relationships on recordNo publicly disclosed debt instruments or credit facilities found for MIRA Pharmaceuticals, Inc..
MIRA Pharmaceuticals, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for MIRA Pharmaceuticals, Inc..
MIRA Pharmaceuticals, Inc. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for MIRA Pharmaceuticals, Inc..
MIRA Pharmaceuticals, Inc. Extended Supply Chain Network
